Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
82,861,193
-
Share change
-
+2,888,390
-
Total reported value
-
$627,171,612
-
Put/Call ratio
-
15%
-
Price per share
-
$7.57
-
Number of holders
-
114
-
Value change
-
+$36,139,511
-
Number of buys
-
68
-
Number of sells
-
49
Institutional Holders of ACHILLION PHARMACEUTICALS IN - COM (ACHN) as of Q2 2014
As of 30 Jun 2014,
ACHILLION PHARMACEUTICALS IN - COM (ACHN) was held by
114 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
82,861,193 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, QVT Financial LP, FMR LLC, Camber Capital Management LLC, VANGUARD GROUP INC, Capital World Investors, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., GOLDMAN SACHS GROUP INC, and BROOKSIDE CAPITAL MANAGEMENT LLC.
This page lists
114
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.